0K05.LSE Medifast Inc.
- Market cap
- -
- P/E
- 0.9x
- P/B
- -
- ROE
- -16.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 0K05.LSE undervalued?
Graham numberThe Graham number of Medifast Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Medifast Inc. fundamental analysis
No fundamental analysis for Medifast Inc. yet.
Medifast Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Medifast Inc.
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mi…
Full company profileMedifast Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Medifast Inc. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 275M | 302M | 501M | 714M | 935M | 1.53B | 1.60B | 1.07B | 602M | 386M | 299M |
| Gross Profit | 206M | 228M | 380M | 537M | 698M | 1.13B | 1.15B | 776M | 445M | 275M | 209M |
| Operating Income | 34.1M | 39.6M | 69.1M | 91.0M | 134M | 216M | 216M | 126M | 2.88M | -14.2M | -12.5M |
| EBITDA | 39.5M | 43.8M | 73.5M | 95.7M | 142M | 228M | 202M | 147M | 21.2M | -3.71M | -109K |
| Net Income | 17.8M | 27.7M | 55.8M | 77.9M | 103M | 164M | 144M | 99.4M | 2.09M | -18.7M | -30.3M |
| EPS | 1.49 | 2.29 | 4.62 | 6.43 | 8.68 | 14 | 13 | 9.10 | 0.19 | -1.70 | -2.71 |
| Balance Sheet | |||||||||||
| Total Assets | 121M | 146M | 171M | 199M | 284M | 412M | 333M | 326M | 293M | 257M | 240M |
| Total Liabilities | 25.2M | 37.3M | 62.3M | 94.2M | 127M | 210M | 178M | 108M | 83.1M | 58.1M | 59.5M |
| Shareholders' Equity | 96.0M | 109M | 109M | 105M | 157M | 202M | 155M | 201M | 210M | 199M | 180M |
| Cash & Short-term Investments | 76.8M | 98.8M | 101M | 92.7M | 174M | 110M | 87.7M | 150M | 162M | 167M | 173M |
| Total Debt | 779K | - | - | 13.6M | 11.2M | 32.5M | 26.1M | 22.0M | 16.1M | 16.8M | 20.7M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 25.4M | 43.2M | 60.8M | 84.3M | 145M | 94.5M | 195M | 148M | 24.5M | 6.86M | 7.00M |
| Capital Expenditure | 2.88M | 3.24M | 4.94M | 10.1M | 5.89M | 34.2M | 16.7M | 6.48M | 7.45M | 5.61M | 3.32M |
| Free Cash Flow | 22.5M | 40.0M | 55.9M | 74.2M | 139M | 60.3M | 178M | 141M | 17.0M | 1.25M | 3.68M |
| Ratios | |||||||||||
| ROE | 18.6% | 25.5% | 51.1% | 74.3% | 65.4% | 81.0% | 92.6% | 49.3% | 1.0% | -9.4% | -16.8% |
| ROA | 14.7% | 19.0% | 32.5% | 39.1% | 36.2% | 39.8% | 43.1% | 30.5% | 0.7% | -7.3% | -12.6% |
| Net Profit Margin | 6.5% | 9.2% | 11.1% | 10.9% | 11.0% | 10.7% | 9.0% | 9.3% | 0.3% | -4.8% | -10.1% |
| Debt to Equity | 0.01x | - | - | 0.13x | 0.07x | 0.16x | 0.17x | 0.11x | 0.08x | 0.08x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Medifast Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 195K | 0.02 | - |
| 2024 | 715K | 0.07 | 34.2% |
| 2023 | USD 73.0M | 6.69 | 73.4% |
| 2022 | USD 71.6M | 6.35 | 49.9% |
| 2021 | USD 63.9M | 5.41 | 38.9% |
| 2020 | USD 53.2M | 4.49 | 51.7% |
| 2019 | USD 35.4M | 2.92 | 45.4% |
| 2018 | USD 23.2M | 1.92 | 41.5% |
| 2017 | USD 15.4M | 1.27 | 55.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Medifast Inc.
- Insiders 4.33%
- Institutions 74.29%
- Public & others 21.38%
- Free float 8.52M
Medifast Inc. company profile
- Company name
- Medifast Inc.
- Ticker
- 0K05.LSE
- Exchange
- London Exchange
- Sector
- Consumer Cyclical
- Industry
- Commercial Services & Supplies
- Employees
- 380
- Fiscal year end
- December
- Address
- 1501 S. Clinton Street, Baltimore, MD, United States, 21224
- Phone
- 410 581 8042
- Website
- medifastinc.com
About Medifast Inc.
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
Medifast Inc. management
5- Mr. Nicholas M. JohnsonCEO & President · born 1980
- Mr. James P. Maloney CPAChief Financial Officer · born 1968
- Mr. Jonathan Barrett MacKenzieVP of Finance & Chief Accounting Officer · born 1972
- Mr. Matthew DarymanManager of Investor Relations
- Ms. Claudia C. GreningerChief Human Resources Officer · born 1974